1
TITLE: A prospective, international phase 2 study of bortezomib retreatment in patients with relapsed multiple myeloma  Full Text
AUTHORS: Maria T Petrucci; Pilar Giraldo; Paolo Corradini; Adriana Teixeira; Meletios A Dimopoulos; Igor W Blau; Johannes Drach; Ralf Angermund; Nathalie Allietta; Esther Broer; Vivien Mitchell; Joan Blade;
PUBLISHED: 2013, SOURCE: BRITISH JOURNAL OF HAEMATOLOGY, VOLUME: 160, ISSUE: 5
INDEXED IN: Scopus WOS CrossRef: 61
2
TITLE: Multiple Myeloma Treatment Strategies with Novel Agents in 2011: A European Perspective
AUTHORS: Heinz Ludwig; Meral Beksac; Joan Blade; Jamie Cavenagh; Michele Cavo; Michel Delforge; Meletios Dimopoulos; Johannes Drach; Hermann Einsele; Thierry Facon; Hartmut Goldschmidt; Jean Luc Harousseau; Urs Hess; Martin Kropff; Fernando Leal da Costa; Vernon Louw; Hila Magen Nativ; Larisa Mendeleeva; Hareth Nahi; Torben Plesner; Jesus San Miguel; Pieter Sonneveld; Miklos Udvardy; Pia Sondergeld; Antonio Palumbo; ...More
PUBLISHED: 2011, SOURCE: ONCOLOGIST, VOLUME: 16, ISSUE: 4
INDEXED IN: Scopus WOS CrossRef
3
TITLE: Efficacy and Safety of Re-Treatment with Bortezomib (Velcade (c)) in Patients with Multiple Myeloma: Results from a Prospective International Phase II Trial.
AUTHORS: Maria Teresa Petrucci; Igor W Blau; Paolo Corradini; Meletios A Dimopoulos; Johannes Drach; Pilar Giraldo; Adriana Teixeira; Joan Blade;
PUBLISHED: 2008, SOURCE: 50th Annual Meeting of the American-Society-of-Hematology in BLOOD, VOLUME: 112, ISSUE: 11
INDEXED IN: WOS